» Articles » PMID: 34127476

Newborn Screening for Cystic Fibrosis: Role of Primary Care Providers in Caring for Infants with Positive Screening Results

Abstract

Objective: To explore primary care providers' (PCPs') preferred roles and confidence in caring for infants receiving a positive cystic fibrosis (CF) newborn screening (NBS) result, as well as management of CF family planning issues, given that expanded NBS has resulted in an increase in positive results.

Design: Mailed questionnaire.

Setting: Ontario.

Participants: Ontario FPs, pediatricians, and midwives identified by Newborn Screening Ontario as having had an infant with a positive CF NBS result in their practice in the previous 6 months.

Main Outcome Measure: Primary care providers' preferred roles in providing well-baby care for infants with positive CF screening results.

Results: Overall, 321 of 628 (51%) completed surveys (208 FPs, 68 pediatricians, 45 midwives). For well-baby care for infants confirmed to have CF, 77% of PCPs indicated they would not provide total care (ie, 68% would share care with other specialists and 9% would refer to specialists completely); for infants with an inconclusive CF diagnosis, 50% of PCPs would provide total care, 45% would provide shared care, and 5% would refer to a specialist; for CF carriers, 89% of PCPs would provide total care, 9% would provide shared care, and 2% would refer. Half (54%) of PCPs were extremely or very confident in providing reassurance about CF carriers' health. Only 25% knew how to order parents' CF carrier testing; 67% knew how to refer for prenatal diagnosis. Confidence in reassuring parents about the health of CF carrier children was associated with providing total well-baby care for CF carriers (risk ratio of 1.50; 95% CI 1.14 to 1.97) and infants with an inconclusive diagnosis (risk ratio of 3.30; 95% CI 1.34 to 8.16).

Conclusion: Most PCPs indicated willingness to treat infants with a range of CF NBS results in some capacity. It is concerning that some indicated CF carriers should have specialist involvement and only half were extremely or very confident about reassuring families about carrier status. This raises issues about possible medicalization of those with carrier status, prompting the need for PCP education about genetic disorders and the meaning of genetic test results.

Citing Articles

Integrated Care for People Living With Rare Disease: A Scoping Review on Primary Care Models in Organization for Economic Cooperation and Development Countries.

Vidic N, McGlynn A, Abdi F, Tam C, Crampton R, Lim K J Prim Care Community Health. 2025; 16:21501319241311567.

PMID: 39772949 PMC: 11707790. DOI: 10.1177/21501319241311567.


Diagnosing cystic fibrosis in low- and middle-income countries: challenges and strategies.

Fuhrer M, Zampoli M, Abriel H Orphanet J Rare Dis. 2024; 19(1):482.

PMID: 39707455 PMC: 11662431. DOI: 10.1186/s13023-024-03506-1.


Current Status of Newborn Bloodspot Screening Worldwide 2024: A Comprehensive Review of Recent Activities (2020-2023).

Therrell B, Padilla C, Borrajo G, Khneisser I, Schielen P, Knight-Madden J Int J Neonatal Screen. 2024; 10(2).

PMID: 38920845 PMC: 11203842. DOI: 10.3390/ijns10020038.


Single-centre prospective evaluation of the first 5 years of cystic fibrosis newborn screening in Germany.

Gesenhues F, Michel K, Greve T, Roschinger W, Gothe F, Nubling J ERJ Open Res. 2024; 10(2).

PMID: 38444668 PMC: 10910348. DOI: 10.1183/23120541.00699-2023.


Current State of Genomics in Nursing: A Scoping Review of Healthcare Provider Oriented (Clinical and Educational) Outcomes (2012-2022).

Thomas J, Keels J, Calzone K, Badzek L, Dewell S, Patch C Genes (Basel). 2023; 14(11).

PMID: 38002957 PMC: 10671121. DOI: 10.3390/genes14112013.


References
1.
Castellani C, Southern K, Brownlee K, Dankert Roelse J, Duff A, Farrell M . European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros. 2009; 8(3):153-73. DOI: 10.1016/j.jcf.2009.01.004. View

2.
Hayeems R, Miller F, Little J, Carroll J, Allanson J, Chakraborty P . Informing parents about expanded newborn screening: influences on provider involvement. Pediatrics. 2009; 124(3):950-8. DOI: 10.1542/peds.2008-3148. View

3.
Harding B, Webber C, Ruhland L, Dalgarno N, Armour C, Birtwhistle R . Primary care providers' lived experiences of genetics in practice. J Community Genet. 2018; 10(1):85-93. PMC: 6325046. DOI: 10.1007/s12687-018-0364-6. View

4.
Beucher J, Leray E, Deneuville E, Roblin M, Pin I, Bremont F . Psychological effects of false-positive results in cystic fibrosis newborn screening: a two-year follow-up. J Pediatr. 2010; 156(5):771-6, 776.e1. DOI: 10.1016/j.jpeds.2009.12.003. View

5.
Koopmans J, Friedman Ross L . Does familiarity breed acceptance? The influence of policy on physicians' attitudes toward newborn screening programs. Pediatrics. 2006; 117(5):1477-85. DOI: 10.1542/peds.2005-1990. View